Polaris Genomics

Private

Gaithersburg, MarylandHealthcare & Life Scienceshttps://polarisgenomics.com/

Last Round

Seed

Nov 1, 2023

Total Funding Raised

$5.41M

Company Overview

Polaris Genomics is a biotechnology company that develops AI-powered genomic diagnostics and therapeutics for mental health and neuropsychiatric conditions.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Mental Health, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Data as a Service

AI Layer

Application

Keywords

precision mental healthbiomarker discoverygenomicsRNA transcriptomicsneuropsychiatric diagnosticsAI-powered genomicsPTSD screeningbioinformaticsclinical trial designdrug developmentmental health techdigital psychiatrybiotechmolecular diagnosticspatient stratification

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Polaris Genomics Comps

Public and private peers based on sector, stage, and business model.

Polaris Genomics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Polaris Genomics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Nov 1, 2023
Grant	Nov 2, 2022
Grant	Sep 20, 2022
Grant	Jul 19, 2022
Grant	Jan 5, 2022
Grant	Oct 1, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Tshaka Cunningham

Director of Research Development, Chief Scientific Officer, Co-founder

Founding Team

Charles Cathlin

Chief Executive Officer

Executive Team

Polaris Genomics Investors

Notable investors and investment history

Polaris Genomics investors
Investor	Rounds
TEDCO	Seed
Wavemaker Three-Sixty Health	Seed
Maryland Industrial Partnerships (MIPS)	Grant
Viking Global Investors	Seed
AFVentures	Grant
Illumina Accelerator	Accelerator

View all Investors

Polaris Genomics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Polaris Genomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Polaris Genomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersGaithersburg, Maryland

Employee Range15

Year Founded2017

Last FundingNov 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.